|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4745 | |
| A61P 7/00 | |||
| A61P 9/00 | |||
| A61P 37/00 | |||
| A61P 43/00 | |||
| A61P 25/00 | |||
| A61P 27/02 | |||
| A61P 31/04 | |||
| A61P 31/12 | |||
| A61P 35/00 | |||
| A61P 11/00 |
| (11) | Number of the document | 2129379 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08730106.5 |
| Date of filing the European patent application | 2008-02-19 | |
| (97) | Date of publication of the European application | 2009-12-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/054236 |
| Date | 2008-02-19 |
| (87) | Number | WO 2008/103636 |
| Date | 2008-08-28 |
| (30) | Number | Date | Country code |
| 890641 P | 2007-02-20 | US |
| (72) |
BRACHMANN, Saskia Maria, CH
FINAN, Peter, US
FRITSCH, Christine, FR
GARCIA-ECHEVERRIA, Carlos, CH
MAIRA, Sauveur-Michel, FR
MURPHY, Leon, US
NICKLIN, Paul Leslie, GB
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | IMIDAZOQUINOLINES AS DUAL LIPID KINASE AND MTOR INHIBITORS |
| IMIDAZOQUINOLINES AS DUAL LIPID KINASE AND MTOR INHIBITORS |